Application of threedimensional cell culture model in cancer research

doi:10.3760/cma.j.issn.1673-422X.2015.07.015

Abstract

Abstract: Threedimensional cell culture is widely recognized as a model in vitro that can better simulate the interaction between tumor cells in vivo and cell microenvironment. Compared with the traditional twodimensional cell culture, it has obvious advantages in the study of the observation of tumor cells biological behavior, tumor resistance, radiation insensitivity, gene expression in vivo and in other aspects of the study. It can provide a valuable model in vitro for experimental study on the basis of tumor.

Key words: Neoplasm metastasis, Cell culture techniques, Tumor microenvironment

Feng Fei, Qin Songbing. Application of threedimensional cell culture model in cancer research[J]. Journal of International Oncology, 2015, 42(7): 532-534.

References

［1］ Tang JH, Cui JF, Chen RX, et al. A threedimensional cell biology model of human hepatocellular carcinoma in vitro［J］. Tumour Biol, 2011, 32(3): 469-479. ［2］ Tsuji K, Kawauchi S, Saito S, et al. Breast cancer cell lines carry cell linespecific genomic alterations that are distinct from aberrations in breast cancer tissues: comparison of the CGH profiles between cancer cell lines and primary cancer tissues［J］. BMC Cancer, 2010, 10: 15. ［3］ Perkel JM. Curing cell lines［J］. Biotechniques, 2011, 51(2): 85-90. ［4］ Cheon DJ, Orsulic S. Mouse models of cancer［J］. Annu Rev Pathol, 2011, 6: 95-119. ［5］ Herschkowitz JI, Simin K, Weigman VJ, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors［J］. Genome Biol, 2007, 8(5): R76. ［6］ Larue L, Beermann F. Cutaneous melanoma in genetically modified animals［J］. Pigment Cell Res, 2007, 20(6): 485-497. ［7］ Ghajar CM, Bissell MJ. Tumor engineering: the other face of tissue engineering［J］. Tissue Eng Part A, 2010, 16(7): 2153-2156. ［8］ SantiagoWalker A, Li L, Haass NK, et al. Melanocytes: from morphology to application［J］. Skin Pharmacol Physiol, 2009, 22(2): 114-121. ［9］ Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue［J］. Nat Rev Mol Cell Biol, 2007, 8(10): 839-845. ［10］ Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation［J］. Cell, 2011, 144(5): 646-674. ［11］ De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelialmesenchymal transitions at the cancer invasion front［J］. Histochem Cell Biol, 2008, 130(3): 481-494. ［12］ Lopez JI, Kang I, You WK, et al. In situ force mapping of mammary gland transformation［J］. Integr Biol (Camb), 2011, 3(9): 910-921. ［13］ Egeblad M, Ewald AJ, Askautrud HA, et al. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy［J］. Dis Model Mech, 2008, 1(2-3): 155-167; discussion 165. ［14］ Holliday DL, Brouilette KT, Markert A, et al. Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression［J］. Breast Cancer Res, 2009, 11(1): R3. ［15］ Novitskaya V, Romanska H, Dawoud M, et al. Tetraspanin CD151 regulates growth of mammary epithelial cells in threedimensional extracellular matrix: implication for mammary ductal carcinoma in situ［J］. Cancer Res, 2010, 70(11): 4698-4708. ［16］ LaBarge MA, Nelson CM, Villadsen R, et al. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments［J］.Integr Biol (Camb), 2009, 1(1): 70-79. ［17］ Zhou S, Li F, Xiao J, et al. Isolation and identification of cancer stem cells from human osteosarcom by serumfree threedimensional culture combined with anticancer drugs［J］. J Huazhong Univ Sci Technol Med Sci, 2010, 30(1): 81-84. ［18］ WangZZ, AuP, ChenT, et al. Endothelial cells derivedfromhuman embryonic stem cells form durable blood vessels in vivo［J］. Nat Biotechnol, 2007, 25(3): 317-318. ［19］ Micalizzi DS, Ford HL. Epithelialmesenchymal transition in development and cancer［J］. Future Oncol, 2009, 5(8): 1129-1143. ［20］ Crigler L, Kazhanie A, Yoon TJ, et al. Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages［J］. FASEB J, 2007, 21(9): 2050-2063. ［21］ Fischbach C, Chen R, Matsumoto T, et al. Engineering tumors with 3D scaffolds［J］. Nat Methods, 2007, 4(10): 855-860. ［22］ Nelson CM, Inman JL, Bissell MJ. Threedimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression［J］. Nat Protoc, 2008, 3(4): 674-678. ［23］ Nelson CM, Khauv D, Bissell MJ, et al. Change in cell shape is required for matrix metalloproteinaseinduced epithelialmesenchymal transition of mammary epithelial cells［J］. J Cell Biochem, 2008, 105(1): 25-33. ［24］ Jo M, Eastman BM, Webb DL, et al. Cell signaling by urokinasetype plasminogen activator receptor induces stem celllike properties in breast cancer cells［J］. Cancer Res, 2010, 70(21): 8948-8958. ［25］ Indovina P, Rainaldi G, Santini MT. Hypoxia increases adhesion and spreading of MG63 threedimensional tumor spheroids［J］. Anticancer Res, 2008, 28(2A): 1013-1022. ［26］ Harma V, Virtanen J, Makela R, et al. A comprehensive panel of threedimensional models for studies of prostate cancer growth, invasion and drug responses［J］. PLoS One, 2010, 5(5): e10431.

[1]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[2]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.
[3]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong. Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer [J]. Journal of International Oncology, 2024, 51(4): 235-238.
[4]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing. Progress of radiotherapy in oligometastatic non-small cell lung cancer [J]. Journal of International Oncology, 2024, 51(3): 170-174.
[5]	Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan. Research progress on the histopathological growth patterns of colorectal liver metastasis [J]. Journal of International Oncology, 2024, 51(2): 114-118.
[6]	Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie. Research progress of myeloid-derived suppressor cells in tumor angiogenesis [J]. Journal of International Oncology, 2024, 51(1): 50-54.
[7]	Gu Huayan, Zhu Teng, Guo Guilong. Breast microbiota and breast cancer： present and future [J]. Journal of International Oncology, 2024, 51(1): 55-58.
[8]	Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying. Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2023, 50(8): 475-483.
[9]	Yang Lirong, Wang Yufeng. Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer [J]. Journal of International Oncology, 2023, 50(4): 220-226.
[10]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng. Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance [J]. Journal of International Oncology, 2023, 50(4): 227-230.
[11]	Ding Hao, Ying Jintao, Fu Maoyong. Research progress of CAR-T in the treatment of esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2023, 50(4): 231-235.
[12]	Cao Mengqing, Xu Zhiyong, Shi Yuting, Wang Kai. Role of tertiary lymphoid structures in tumor immune microenvironment regulation and anti-tumor therapy [J]. Journal of International Oncology, 2023, 50(3): 169-173.
[13]	Xu Liangfu, Li Yuanfei. Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer [J]. Journal of International Oncology, 2023, 50(3): 186-190.
[14]	Ma Peihan, Zhang Lingming, Lu Ning, Zhang Mingxin. Effect of anesthesia on the recurrence and metastasis of hepatocellular carcinoma [J]. Journal of International Oncology, 2023, 50(2): 117-121.
[15]	Zhu Yi, Chen Jian. Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects [J]. Journal of International Oncology, 2023, 50(12): 729-733.